Clinical Usefulness of the QMAC-dRAST System for AmpC β-lactamase-Producing Enterobacterales
Background: Rapid antimicrobial susceptibility testing (RAST) is important for the appropriate treatment of bloodstream infections. The QMAC-dRAST system (QuantaMatrix Inc., Korea) can directly perform RAST using positive blood culture samples with microscopic imaging. This study aimed to evaluate t...
Main Authors: | Heekang Choi, Daewon Kim, Mijung Kwon, Jung-Hyun Byun, Bonghwan Jin, Ki-Ho Hong, Hyukmin Lee, Dongeun Yong |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Clinical Microbiology
2022-12-01
|
Series: | Annals of Clinical Microbiology |
Subjects: | |
Online Access: | https://www.acm.or.kr/acm_22-011/ |
Similar Items
-
Cefepime vs carbapenems for treating third-generation cephalosporin-resistant AmpC β-lactamase-hyperproducing Enterobacterales bloodstream infections: a multicenter retrospective study
by: Baptiste Hoellinger, et al.
Published: (2023-09-01) -
Molecular Characterization of AmpC β-lactamases in Enterobacteriaceae
by: D. Bindu, et al.
Published: (2022-12-01) -
Early Treatment Outcomes for Bloodstream Infections Caused by Potential AmpC Beta-Lactamase-Producing Enterobacterales with Focus on Piperacillin/Tazobactam: A Retrospective Cohort Study
by: Lena Herrmann, et al.
Published: (2021-06-01) -
Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
by: Sarah Grace Gunter, et al.
Published: (2020-06-01) -
Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
by: M. Ávila-Núñez, et al.
Published: (2023-08-01)